Bibliography - Disposable Bioprocessing Systems - page 259

Dancette, O.P., Taboureau, J.L., Tournier, E., Charcosset, C., and Blond, P. 1999.
Purification of immunoglobulins G by protein A/G affinity membrane chroma-
tography. J. Chromatogr. B 723: 61-68.
Danckwerts, P.V. 1953. Continuous flow systems: Distribution of residence times.
Chem. Eng. Sci . 2: 1-13.
Davis, J.M. 2007. Hollow fibre cell culture. In Pörtner, R. (ed.), Animal Cell Biotechnology:
Methods and Protocols, Series Methods in Biotechnology , Vol. 24. Totowa, NJ:
Humana Press, 337-352.
Davis, J.M. 2007. Hollow fibre cell culture. In: Pörtner, R (ed.), Animal Cell Biotechnology:
Methods and Protocols . Humana, Totowa, 337-352.
Davis, J.M. 2007. Systems for cell culture scale-up. In Stacey, G. and Davis, J.M. (eds.),
Medicines from Animal Cell Culture . Chichester, UK: John Wiley & Sons, 145-171.
Davis, R.M. and Taylor, G. (1950). The mechanics of large bubbles rising through liq-
uids in tubes. Proc. R Soc. Lond. A 200: 375-392.
DeGrazio, F.L. 2006. The importance of leachables and extractables testing for a
successful product launch. Available: http://pharmtech.fmdpharma.com/
pharmtech/Article/The-Importance-of-Leachables-and-Extractables-Test/
ArticleStandard/Article/detail/482447 .
De Jesus, M.J., Girard, P., Bourgeois, M., Baumgartner, G., Kacko, B., Amstutz, H., and
Wurm, F.M. 2004. TubeSpin satellites: A fast track approach for process develop-
ment with animal cells using shaking technology. Biochem. Eng. J . 17: 217-223.
De Jesus, M.J. and Wurm, FM. 2009. Medium and process optimization for high yield,
high density suspension cultures: From low throughput spinner flasks to high
throughput millilitre reactors. BioProcess Int. 7 (Suppl. 1): 12-17.
Denton, A., Jones, C., and Tarrach, K. 2009. Integration of large-scale chromatography
with nanofiltration for an ovine polyclonal product. Pharm. Technol . 1: 62-70.
DePalma, A. 2002. Options for anchorage-dependent cell culture. Genet. Eng.
Biotechnol. News 22: 58-62.
DePalma, A. 2004. Bioprocessing on the way to total-disposability manufacture.
Genet. Eng. Biotechnol. News 24 (3): 40-41.
DePalma, A. 2005. Liquid mixing: Solid challenges. Available: http://www.
pharmamanufacturing.com/articles/2005/297.html .
DePalma, A. 2006. Bright sky for single-use bioprocess products. Genet. Eng. Biotechnol.
News 26 (3): 50-57.
Desai, M.A., Rayner, M., Burns, M., and Bermingham, D. 2000. Application of chro-
matography in the downstream processing of biomolecules. Methods Biotechnol .
9: 73-94.
De Wilde, D., Noack, U., Kahlert, W., Barbaroux, M., and Greller, G. 2009. Bridging
the gap from reusable to single-use manufacturing with stirred, single-use bio-
reactors. BioProcess Int 7(Suppl 4): 36-42.
DiBlasi, K., Jornitz, M.W., Gottschalk, U., and Priebe, P.M. 2006. Disposable biophar-
maceutical processes—Myth or reality? BioPharm. Int. 11: 2-10.
Diehl, T. 2006. Application of membrane chromatography in the purification of
humanly monoclonal antibodies. Downstream Technology Forum, King of
Prussia, PA.
DiMasi, J.A. and Grabowski, HG. 2007.The cost of biopharmaceutical R&D: Is biotech
different? Manage. Decis. Econ . 28: 469-479.
DIN EN 556. Sterilization of Medical Devices—Requirements for Medical Devices to
Be Designated “Sterile”; http://webstore.ansi.org .